Annual Retained Earnings
-$115.56 M
-$19.38 M-20.15%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual retained earnings is -$115.56 million, with the most recent change of -$19.38 million (-20.15%) on December 31, 2023.
- During the last 3 years, DMAC annual retained earnings has fallen by -$46.65 million (-67.70%).
- DMAC annual retained earnings is now -5765.59% below its all-time high of -$1.97 million, reached on December 31, 2004.
Performance
DMAC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$132.10 M
-$6.27 M-4.99%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly retained earnings is -$132.10 million, with the most recent change of -$6.27 million (-4.99%) on September 30, 2024.
- Over the past year, DMAC quarterly retained earnings has dropped by -$21.70 million (-19.66%).
- DMAC quarterly retained earnings is now -5771.72% below its all-time high of -$2.25 million, reached on December 31, 2005.
Performance
DMAC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DMAC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | -19.7% |
| 3 y3 years | -67.7% | -66.7% |
| 5 y5 years | -151.4% | -66.7% |
DMAC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -60.1% | at low |
| 5 y | 5-year | -104.1% | at low | -133.3% | at low |
| alltime | all time | -5765.6% | at low | -5771.7% | at low |
DiaMedica Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$132.10 M(+5.0%) |
| Jun 2024 | - | -$125.83 M(+4.2%) |
| Mar 2024 | - | -$120.71 M(+4.5%) |
| Dec 2023 | -$115.56 M(+20.2%) | -$115.56 M(+4.7%) |
| Sep 2023 | - | -$110.40 M(+4.2%) |
| Jun 2023 | - | -$105.93 M(+4.4%) |
| Mar 2023 | - | -$101.45 M(+5.5%) |
| Dec 2022 | -$96.18 M(+16.6%) | -$96.18 M(+4.1%) |
| Sep 2022 | - | -$92.43 M(+3.4%) |
| Jun 2022 | - | -$89.37 M(+3.9%) |
| Mar 2022 | - | -$86.01 M(+4.3%) |
| Dec 2021 | -$82.50 M(+19.7%) | -$82.50 M(+4.1%) |
| Sep 2021 | - | -$79.25 M(+4.6%) |
| Jun 2021 | - | -$75.81 M(+4.5%) |
| Mar 2021 | - | -$72.53 M(+5.3%) |
| Dec 2020 | -$68.91 M(+21.7%) | -$68.91 M(+6.5%) |
| Sep 2020 | - | -$64.71 M(+5.2%) |
| Jun 2020 | - | -$61.52 M(+4.2%) |
| Mar 2020 | - | -$59.04 M(+4.3%) |
| Dec 2019 | -$56.62 M(+23.2%) | -$56.62 M(+4.6%) |
| Sep 2019 | - | -$54.14 M(+4.7%) |
| Jun 2019 | - | -$51.69 M(+5.0%) |
| Mar 2019 | - | -$49.22 M(+7.1%) |
| Dec 2018 | -$45.97 M(+14.3%) | -$45.97 M(-17.3%) |
| Sep 2018 | - | -$55.55 M(+1.0%) |
| Jun 2018 | - | -$55.03 M(+6.9%) |
| Mar 2018 | - | -$51.46 M(+27.9%) |
| Dec 2017 | -$40.23 M(+11.8%) | -$40.23 M(-19.5%) |
| Sep 2017 | - | -$49.98 M(+1.8%) |
| Jun 2017 | - | -$49.09 M(+2.2%) |
| Mar 2017 | - | -$48.02 M(+33.5%) |
| Dec 2016 | -$35.97 M(-19.1%) | -$35.97 M(-4.4%) |
| Sep 2016 | - | -$37.65 M(+0.9%) |
| Jun 2016 | - | -$37.30 M(+1.8%) |
| Mar 2016 | - | -$36.65 M(-17.6%) |
| Dec 2015 | -$44.48 M | -$44.48 M(+28.7%) |
| Sep 2015 | - | -$34.57 M(-6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -$37.13 M(+3.1%) |
| Mar 2015 | - | -$36.03 M(-16.0%) |
| Dec 2014 | -$42.89 M(+15.5%) | -$42.89 M(+8.6%) |
| Sep 2014 | - | -$39.48 M(-2.2%) |
| Jun 2014 | - | -$40.38 M(+6.9%) |
| Mar 2014 | - | -$37.79 M(+1.8%) |
| Dec 2013 | -$37.12 M(+16.7%) | -$37.12 M(+0.7%) |
| Sep 2013 | - | -$36.88 M(+5.8%) |
| Jun 2013 | - | -$34.86 M(+3.1%) |
| Mar 2013 | - | -$33.82 M(+6.3%) |
| Dec 2012 | -$31.80 M(+50.1%) | -$31.80 M(+9.5%) |
| Sep 2012 | - | -$29.05 M(+13.4%) |
| Jun 2012 | - | -$25.62 M(+8.9%) |
| Mar 2012 | - | -$23.51 M(+11.0%) |
| Dec 2011 | -$21.19 M(+42.4%) | -$21.19 M(+11.3%) |
| Sep 2011 | - | -$19.04 M(+2.8%) |
| Jun 2011 | - | -$18.51 M(+9.3%) |
| Mar 2011 | - | -$16.93 M(+13.8%) |
| Dec 2010 | -$14.88 M(+46.5%) | -$14.88 M(+17.4%) |
| Sep 2010 | - | -$12.68 M(+12.6%) |
| Jun 2010 | - | -$11.26 M(+3.3%) |
| Mar 2010 | - | -$10.90 M(+7.3%) |
| Dec 2009 | -$10.16 M(+52.9%) | -$10.16 M(+7.7%) |
| Sep 2009 | - | -$9.43 M(+16.0%) |
| Jun 2009 | - | -$8.13 M(+15.3%) |
| Mar 2009 | - | -$7.05 M(+6.1%) |
| Dec 2008 | -$6.64 M(+12.9%) | -$6.64 M(-5.4%) |
| Sep 2008 | - | -$7.03 M(+7.0%) |
| Jun 2008 | - | -$6.57 M(+12.1%) |
| Mar 2008 | - | -$5.86 M(-0.5%) |
| Dec 2007 | -$5.89 M(+95.0%) | -$5.89 M(+12.3%) |
| Sep 2007 | - | -$5.24 M(+16.5%) |
| Jun 2007 | - | -$4.50 M(+39.9%) |
| Mar 2007 | - | -$3.22 M(+6.6%) |
| Dec 2006 | -$3.02 M(+34.2%) | -$3.02 M(+3.1%) |
| Sep 2006 | - | -$2.93 M(+30.1%) |
| Dec 2005 | -$2.25 M(+14.2%) | -$2.25 M |
| Dec 2004 | -$1.97 M | - |
FAQ
- What is DiaMedica Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual retained earnings year-on-year change?
- What is DiaMedica Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly retained earnings year-on-year change?
What is DiaMedica Therapeutics annual retained earnings?
The current annual retained earnings of DMAC is -$115.56 M
What is the all time high annual retained earnings for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual retained earnings is -$1.97 M
What is DiaMedica Therapeutics annual retained earnings year-on-year change?
Over the past year, DMAC annual retained earnings has changed by -$19.38 M (-20.15%)
What is DiaMedica Therapeutics quarterly retained earnings?
The current quarterly retained earnings of DMAC is -$132.10 M
What is the all time high quarterly retained earnings for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly retained earnings is -$2.25 M
What is DiaMedica Therapeutics quarterly retained earnings year-on-year change?
Over the past year, DMAC quarterly retained earnings has changed by -$21.70 M (-19.66%)